Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune System Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01309997
What this trial is testing

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host DiseaseSystemic Scleroderma
Lee, Stephanie 72
Large-scale testing (Phase 3)Ended earlyNCT03283397
What this trial is testing

A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bosnalijek D.D 301
Post-approval studies (Phase 4)Study completedNCT00411697
What this trial is testing

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

Who this might be right for
Hepatitis B
GlaxoSmithKline 301
Not applicableStudy completedNCT03584282
What this trial is testing

Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users

Who this might be right for
HIV/AIDSAdherence, MedicationDrug Use
University of Washington 21
Testing effectiveness (Phase 2)Ended earlyNCT02489123
What this trial is testing

Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Ann Arbor Stage I Mantle Cell LymphomaAnn Arbor Stage II Mantle Cell LymphomaAnn Arbor Stage III Mantle Cell Lymphoma+3 more
University of Washington 8
Not applicableStudy completedNCT06355323
What this trial is testing

Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France

Who this might be right for
Primary ImmunodeficiencyCommon Variable ImmunodeficiencyIgg Subclass Deficiency+1 more
CHU de Reims 46
Not applicableLooking for participantsNCT05509959
What this trial is testing

Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement

Who this might be right for
HIV/AIDS
University of California, San Diego 360
Very early researchNot Yet RecruitingNCT06243159
What this trial is testing

JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Shanxi Bethune Hospital 20
Not applicableLooking for participantsNCT06903780
What this trial is testing

Experience of Biologic Treatments for Severe Asthma: a Survey

Who this might be right for
Severe Asthma
Royal Devon and Exeter NHS Foundation Trust 400
Not applicableEnded earlyNCT01196780
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,240
Large-scale testing (Phase 3)Study completedNCT01356680
What this trial is testing

HD17 for Intermediate Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 1,100
Not applicableStudy completedNCT00699179
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,308
Not applicableUnknownNCT03152396
What this trial is testing

Pharmacist CVD Intervention for Patients With Inflammatory Arthritis

Who this might be right for
Inflammatory ArthritisCardiovascular Risk FactorRheumatoid Arthritis+2 more
Epidemiology Coordinating and Research Centre, Canada 100
Early research (Phase 1)Looking for participantsNCT06227026
What this trial is testing

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma
University of Utah 10
Testing effectiveness (Phase 2)Study completedNCT01245426
What this trial is testing

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Who this might be right for
Asthma
GlaxoSmithKline 136
Not applicableUnknownNCT06107478
What this trial is testing

Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Centre Leon Berard 181
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Not applicableWithdrawnNCT02525835
What this trial is testing

Tissue Sodium in Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus
Vanderbilt University
Testing effectiveness (Phase 2)Study completedNCT02249676
What this trial is testing

Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Devic's SyndromeDevic's Neuromyelitis OpticaDevic Syndrome+2 more
Tianjin Medical University General Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01403376
What this trial is testing

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide

Who this might be right for
Multiple Sclerosis
Sanofi 128
Next Page